Zepatier

Country: European Union

Language: Bulgarian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

днес компанията открива, развива, grazoprevir

Available from:

Merck Sharp & Dohme B.V.

ATC code:

J05AP54

INN (International Name):

elbasvir, grazoprevir

Therapeutic group:

Direct acting antivirals, Antivirals for systemic use, Antivirals for treatment of HCV infections

Therapeutic area:

Хепатит C, хроничен

Therapeutic indications:

ZEPATIER is indicated for the treatment of chronic hepatitis C (CHC) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 и 5. Вирусът на хепатит С (HCV) генотип-специфична активност виж раздели 4. 4 и 5.

Product summary:

Revision: 13

Authorization status:

упълномощен

Authorization date:

2016-07-22

Patient Information leaflet

                                47
Б. ЛИСТОВКА
48
ЛИСТОВКА: ИНФОРМАЦИЯ ЗА ПОТРЕБИТЕЛЯ
ZEPATIER 50 MG/100
MG ФИЛМИРАНИ ТАБЛЕТКИ
елбасвир/гразопревир (
el
basvir/grazoprevir
)
ПРОЧЕТЕТЕ ВНИМАТЕЛНО ЦЯЛАТА ЛИСТОВКА,
ПРЕДИ ДА ЗАПОЧНЕТЕ ДА ПРИЕМАТЕ ТОВА
ЛЕКАРСТВО,
ТЪЙ КАТО ТЯ
СЪДЪРЖА ВАЖНА ЗА
ВАС ИНФОРМАЦИЯ.
-
Запазете тази листовка. Може да се
наложи да я прочетете отново.
-
Ако имате някакви допълнителни
въпроси, попитайте Вашия лекар или
фармацевт.
-
Това лекарство е предписано лично на
Вас. Не го преотстъпвайте на други
хора
.
То може
да им навреди, независимо че
признаците на тяхното заболяване са
същите като Вашите.
-
Ако получите някакви нежелани
реакции, уведомете Вашия лекар или
фармацевт.
Това
включва и всички възможни
нежелани реакции, неописани в тази
листовка. Вижте
точка
4.
КАКВО СЪДЪРЖА ТАЗИ ЛИСТОВКА
1.
Какво представлява ZEPATIER и за какво се
използва
2.
Какво трябва да знаете, преди да
приемете ZEPATIER
3.
Как да приемате ZEPA
TIER
4.
Възможни нежелани реакции
5.
Как да съхранявате
ZEPATIER
6.
Съдържание на опаковката и
допълнителна
информация
1.
КАКВО ПРЕДСТАВЛЯВА ZEPATIER И ЗА КАКВО СЕ
ИЗПОЛЗВА
КАКВО ПРЕДСТАВЛЯВА ZEPATIER
ZEPATIER е противовирусно лекарство,
което съдържа активните 
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                1
ПРИЛОЖЕНИЕ I
КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Spanish 21-11-2022
Public Assessment Report Public Assessment Report Spanish 09-02-2022
Patient Information leaflet Patient Information leaflet Czech 21-11-2022
Public Assessment Report Public Assessment Report Czech 09-02-2022
Patient Information leaflet Patient Information leaflet Danish 21-11-2022
Public Assessment Report Public Assessment Report Danish 09-02-2022
Patient Information leaflet Patient Information leaflet German 21-11-2022
Public Assessment Report Public Assessment Report German 09-02-2022
Patient Information leaflet Patient Information leaflet Estonian 21-11-2022
Public Assessment Report Public Assessment Report Estonian 09-02-2022
Patient Information leaflet Patient Information leaflet Greek 21-11-2022
Public Assessment Report Public Assessment Report Greek 09-02-2022
Patient Information leaflet Patient Information leaflet English 07-07-2022
Public Assessment Report Public Assessment Report English 09-02-2022
Patient Information leaflet Patient Information leaflet French 21-11-2022
Public Assessment Report Public Assessment Report French 09-02-2022
Patient Information leaflet Patient Information leaflet Italian 21-11-2022
Public Assessment Report Public Assessment Report Italian 09-02-2022
Patient Information leaflet Patient Information leaflet Latvian 21-11-2022
Public Assessment Report Public Assessment Report Latvian 09-02-2022
Patient Information leaflet Patient Information leaflet Lithuanian 21-11-2022
Summary of Product characteristics Summary of Product characteristics Lithuanian 21-11-2022
Public Assessment Report Public Assessment Report Lithuanian 09-02-2022
Patient Information leaflet Patient Information leaflet Hungarian 21-11-2022
Summary of Product characteristics Summary of Product characteristics Hungarian 21-11-2022
Public Assessment Report Public Assessment Report Hungarian 09-02-2022
Patient Information leaflet Patient Information leaflet Maltese 21-11-2022
Public Assessment Report Public Assessment Report Maltese 09-02-2022
Patient Information leaflet Patient Information leaflet Dutch 21-11-2022
Public Assessment Report Public Assessment Report Dutch 09-02-2022
Patient Information leaflet Patient Information leaflet Polish 21-11-2022
Public Assessment Report Public Assessment Report Polish 09-02-2022
Patient Information leaflet Patient Information leaflet Portuguese 21-11-2022
Summary of Product characteristics Summary of Product characteristics Portuguese 21-11-2022
Public Assessment Report Public Assessment Report Portuguese 09-02-2022
Patient Information leaflet Patient Information leaflet Romanian 21-11-2022
Public Assessment Report Public Assessment Report Romanian 09-02-2022
Patient Information leaflet Patient Information leaflet Slovak 21-11-2022
Public Assessment Report Public Assessment Report Slovak 09-02-2022
Patient Information leaflet Patient Information leaflet Slovenian 21-11-2022
Summary of Product characteristics Summary of Product characteristics Slovenian 21-11-2022
Public Assessment Report Public Assessment Report Slovenian 09-02-2022
Patient Information leaflet Patient Information leaflet Finnish 21-11-2022
Public Assessment Report Public Assessment Report Finnish 09-02-2022
Patient Information leaflet Patient Information leaflet Swedish 21-11-2022
Public Assessment Report Public Assessment Report Swedish 09-02-2022
Patient Information leaflet Patient Information leaflet Norwegian 21-11-2022
Summary of Product characteristics Summary of Product characteristics Norwegian 21-11-2022
Patient Information leaflet Patient Information leaflet Icelandic 21-11-2022
Summary of Product characteristics Summary of Product characteristics Icelandic 21-11-2022
Patient Information leaflet Patient Information leaflet Croatian 21-11-2022
Public Assessment Report Public Assessment Report Croatian 09-02-2022

View documents history